Family Medicine & Primary Care Review

Abstract

1/2024 vol. 26
Review paper

Towards better protection of older people against influenza and its complications. Polish recommendations for HD influenza vaccine

  1. Department of Social Medicine and Public Health, Warsaw Medical University, Warsaw, Poland; Polish Society of Family Medicine
  2. Department of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education, Warsaw, Poland; Polish Cardiac Society
  3. Internal Medicine and Geriatrics Department, H. Klimontowicz Hospital, Gorlice, Poland; Polish Gerontology Society
  4. Department of Pediatrics with Clinical Decisions Unit, Medical University of Warsaw, Warsaw, Poland; Polish Vaccinology Society; National Infectious Diseases Prevention Program
  5. Department of Family Medicine, Wroclaw Medical University, Wroclaw, Poland; Polish Society of Family Medicine; National Infectious Diseases Prevention Program
  6. Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland; Polish Cardiac Society
  7. Department of Preventive Medicine, Poznan University of Medical Sciences, Poznan, Poland; Polish Vaccinology Society
  8. Department of Clinical Genetics, Medical University of Lodz, Lodz, Poland; Polish Diabetes Association
  9. Department of General and Oncological Pulmonology, Medical Univer-sity of Lodz, Lodz, Poland; National Infectious Diseases Prevention Program
Family Medicine & Primary Care Review 2024; 26(1): 116–122
Online publish date: 2024/01/31
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Annual vaccination is the most effective protection against influenza and its serious complications. It is especially important for people at high risk of severe course of the disease and serious complications: individuals with specific chronic medical conditions, pregnant women, children aged 6–59 months, older people, and healthcare workers. Despite a progressive increase in seasonal vaccine coverage, influenza-related morbidity, mortality, and hospitalization rates remain high and have continued to increase in people aged 65 years and over. Standard vaccines against influenza are less efficient in this group due to immunosenescence. Consequently, more effective vaccines are needed to prevent influenza and its complications in older adults.
Share
without publication fees
Coverage in
Integrated with